2001
DOI: 10.1046/j.1365-3156.2001.00666.x
|View full text |Cite
|
Sign up to set email alerts
|

Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
11
0

Year Published

2002
2002
2024
2024

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 10 publications
3
11
0
Order By: Relevance
“…On the other hand, the test does not seem suitable for follow-up and evaluation of control programmes because a considerable number of infected individuals remain antigen positives for more than two years after DEC treatment 7,21 . Since the prevalence of filariasis tends to fall while applying the control measures, it becomes important to utilise tests with higher specificity and, consequently, higher positive predictive value.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, the test does not seem suitable for follow-up and evaluation of control programmes because a considerable number of infected individuals remain antigen positives for more than two years after DEC treatment 7,21 . Since the prevalence of filariasis tends to fall while applying the control measures, it becomes important to utilise tests with higher specificity and, consequently, higher positive predictive value.…”
Section: Discussionmentioning
confidence: 99%
“…[23][24][25] Antigen levels were monitored between 1994 and 1997 in residents of two treatment units (Table 2). Fewer than 20 percent of subjects who were antigen-positive before the trial began were antigen-negative one year after the third annual treatment, though mean antigen levels decreased by 79 percent.…”
Section: Effect On Filarial Antigen Levelmentioning
confidence: 99%
“…Although the parasitological methods are 100% specifi c, they lose their usefulness after the initiation of MDA due to the potent microfi laricide effect of the antifi larial drugs, which yield a dramatic decrease in microfi laremia 16,44 . However, studies have shown that patients can remain infected with detectable levels of antigenemia even after several courses of treatment 16,24,45,46 . These issues limit the use of the antigen-based tests, such as the AD-12 and Og4C3 tests, in the assessment of treatment effectiveness, both at the individual and population levels.…”
Section: Discussionmentioning
confidence: 99%
“…This test detects CFA using a monoclonal antibody against antigens of the bovine parasite Onchocerca gibsoni, which has no known cross-reactivity with other human helminthes. The test provides quantitative results that enable the observation of variations in antigenemia levels after treatment [18][19][20][21][22][23][24] .…”
mentioning
confidence: 99%